MUFG Americas’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-9,486
| Closed | -$805K | – | 91 |
|
|
2022
Q3 | $805K | Sell |
9,486
-318
| -3% | -$27K | 0.02% | 270 |
|
|
2022
Q2 | $812K | Sell |
9,804
-364
| -4% | -$30.1K | 0.02% | 277 |
|
|
2022
Q1 | $783K | Buy |
10,168
+258
| +3% | +$19.9K | 0.02% | 282 |
|
|
2021
Q4 | $875K | Sell |
9,910
-7,336
| -43% | -$648K | 0.02% | 278 |
|
|
2021
Q3 | $1.33M | Sell |
17,246
-880
| -5% | -$68K | 0.02% | 245 |
|
|
2021
Q2 | $1.51M | Buy |
18,126
+1,772
| +11% | +$148K | 0.02% | 233 |
|
|
2021
Q1 | $1.24M | Buy |
16,354
+6,875
| +73% | +$519K | 0.02% | 258 |
|
|
2020
Q4 | $831K | Buy |
9,479
+2,104
| +29% | +$184K | 0.01% | 281 |
|
|
2020
Q3 | $561K | Sell |
7,375
-1,949
| -21% | -$148K | 0.01% | 302 |
|
|
2020
Q2 | $1.15M | Buy |
9,324
+1,309
| +16% | +$162K | 0.03% | 250 |
|
|
2020
Q1 | $677K | Buy |
8,015
+1,662
| +26% | +$140K | 0.02% | 277 |
|
|
2019
Q4 | $537K | Buy |
6,353
+4,932
| +347% | +$417K | 0.01% | 327 |
|
|
2019
Q3 | $96K | Buy |
1,421
+1,215
| +590% | +$82.1K | ﹤0.01% | 462 |
|
|
2019
Q2 | $18K | Buy |
+206
| New | +$18K | ﹤0.01% | 652 |
|
|
2014
Q3 | – | Sell |
-37
| Closed | -$2K | – | 1299 |
|
|
2014
Q2 | $2K | Sell |
37
-28
| -43% | -$1.51K | ﹤0.01% | 1084 |
|
|
2014
Q1 | $4K | Buy |
+65
| New | +$4K | ﹤0.01% | 985 |
|
|
2013
Q3 | – | Sell |
-4,000
| Closed | -$223K | – | 1202 |
|
|
2013
Q2 | $223K | Buy |
+4,000
| New | +$223K | ﹤0.01% | 860 |
|